British private insurer Aviva will not pay for Novo's weight-loss drug Wegovy
LONDON, Sept 4 (Reuters) - British private insurer Aviva has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the UK on Monday.
Read more